What type of infection are renal transplant patients particularly at risk for?

What type of infection are renal transplant patients particularly at risk for?

• A. Bacterial infections leading to sepsis
• B. CMV infection
• C. Fungal infections only
• D. Chronic viral infections

Answer: (B)

Renal transplant patients have a significantly heightened risk for cytomegalovirus (CMV) infection primarily due to the immunosuppressive therapy required to prevent organ rejection. This immunosuppression diminishes the patient’s ability to fight off infections, making them particularly vulnerable to opportunistic pathogens. CMV is a member of the herpesvirus family that can remain dormant in the body and reactivate when the immune system is suppressed. Following a renal transplant, the risk of both primary CMV infection and reactivation of latent CMV increases, particularly within the first few months post-transplant when immunosuppression is at its peak. Understanding this risk is crucial for the management of renal transplant patients, as CMV can lead to significant morbidity, including the potential for severe disease that affects the transplanted kidney and overall health. Regular monitoring and preventive antiviral therapy are often employed in these patients to mitigate this risk. While other types of infections can occur in renal transplant patients, such as bacterial and fungal infections, the specific susceptibility to CMV due to immune system compromise emphasizes its distinct and critical importance in this population.

Renal transplant patients have a significantly heightened risk for cytomegalovirus (CMV) infection primarily due to the immunosuppressive therapy required to prevent organ rejection. This immunosuppression diminishes the patient’s ability to fight off infections, making them particularly vulnerable to opportunistic pathogens.

CMV is a member of the herpesvirus family that can remain dormant in the body and reactivate when the immune system is suppressed. Following a renal transplant, the risk of both primary CMV infection and reactivation of latent CMV increases, particularly within the first few months post-transplant when immunosuppression is at its peak.

Understanding this risk is crucial for the management of renal transplant patients, as CMV can lead to significant morbidity, including the potential for severe disease that affects the transplanted kidney and overall health. Regular monitoring and preventive antiviral therapy are often employed in these patients to mitigate this risk.

While other types of infections can occur in renal transplant patients, such as bacterial and fungal infections, the specific susceptibility to CMV due to immune system compromise emphasizes its distinct and critical importance in this population.